Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. 1979

R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie

Neutrophils preexposed to high concentrations of activated complement or synthetic N-formyl methionyl peptides are inhibited in their subsequent spontaneous and chemotactic migratory responses. We have considered the possibility that a part of this nonspecific loss of migratory function may be attributable to the interaction of the leukocytes with reactive forms of oxygen deriving from the cytotaxin-induced burst of oxidative metabolic activity. For these studies we have assessed the effect of preexposure of neutrophils from patients with chronic granulomatous disease to cytotaxins on their subsequent migratory responses. We find that these responses are not altered by preexposure to either cytotaxin. Thus, there appears to be a functional relationship between deactivation and the ability of the normal neutrophil to undergo a cytotaxin-induced respiratory burst.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D006105 Granulomatous Disease, Chronic A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern. Autosomal Recessive Chronic Granulomatous Disease,Chronic Granulomatous Disease,Chronic Granulomatous Disease, Atypical,Chronic Granulomatous Disease, X-Linked,Cytochrome B-Negative Granulomatous Disease, Chronic, X-Linked,Cytochrome B-Positive Granulomatous Disease, Chronic, X-Linked,Granulomatous Disease, Chronic, X-Linked,Granulomatous Disease, Chronic, X-Linked, Variant,X-Linked Chronic Granulomatous Disease,Chronic Granulomatous Disease, X Linked,Chronic Granulomatous Diseases,Granulomatous Diseases, Chronic,X Linked Chronic Granulomatous Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015054 Zymosan Zymosan A

Related Publications

R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
October 1981, Blood,
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
June 1981, Inflammation,
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
September 1980, Journal of the Reticuloendothelial Society,
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
May 1988, Biochemical pharmacology,
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
August 1981, Prostaglandins,
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
December 1982, Journal of immunology (Baltimore, Md. : 1950),
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
October 1980, The Journal of clinical investigation,
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
February 1981, Clinical and experimental immunology,
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
January 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R D Nelson, and R T McCormack, and V D Fiegel, and M Herron, and R L Simmons, and P G Quie
May 1981, Infection and immunity,
Copied contents to your clipboard!